Healthcare Distribution Alliance – Patients Move Us.
Share Print
News

News

FEATURED NEWS

Results: 26 Articles found.
  • HDA Research Foundation Launches Scholarship Program
    October 11, 2018

    The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies.

  • HDA Announces Drew and Mauch to Lead Board of Directors
    October 2, 2018

    The Healthcare Distribution Alliance (HDA) announces today the election of Greg Drew, President of Value Drug Company, as Chairman of HDA’s Board of Directors. Robert Mauch, PhD, PharmD, EVP and Group President at AmerisourceBergen Corporation, was elected Vice Chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting.

  • AAOA Launches Pharmacy Toolkit to Increase Pharmacist-Patient Engagement Around Safe Use, Storage and Disposal of Opioids
    September 18, 2018

    Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.

  • HDA Statement on Senate Passage of Legislation to Address Opioid Abuse Epidemic
    September 17, 2018

    Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).

  • HDA Research Foundation Report Analyzes Reverse Distribution of Pharmaceutical Products
    August 6, 2018

    A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4 percent of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value.

Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | P | O365